Old Web
English
Sign In
Acemap
>
Paper
>
P263 Influence of Crohn′s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study
P263 Influence of Crohn′s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study
2021
M Chaparro
I. Bastón Rey
E. Fernández-Salgado
J Gonzalez Garcia
Laura Ramos
M.T. Diz-Lois Palomares
F Argüelles
E. Iglesias Flores
M Cabelo
S Rubio Iturria
A. Núñez Ortiz
Mara Charro
Daniel Ginard
C Dueñas Sadornil
O. Merino Ochoa
B David
E. Iyo
A. Gutiérrez Casbas
P. Ramírez de la Piscina
M.M. Bosca Watts
Maite Arroyo
M Garcia
E Hinojosa
Jordi Gordillo
P. Martínez Montiel
B. Velayos Jiménez
C. Quílez Ivorra
J M Vázque morón
J.M Huguet
Y. Gonzalez Lama
A.I. Muñagorri Santos
V M Amo
M D Martín Arranz
F. J. Bermejo
J. Martínez Cadilla
P. Fradejas Salazar
C Novella
E Vispo
M. Barreiro de Acosta
Javier P. Gisbert
Keywords:
Medicine
Retention rate
Internal medicine
Inflammatory bowel disease
Predictor variable
Phenotype
Gastroenterology
Survival analysis
Crohn's disease
Ustekinumab
Log-rank test
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]